Affiliation:
1. Institut de Recherche en Science de la Santé (IRSS), Clinical Research Unit of Nanoro, Nanoro (CRUN), Ouagadougou 11 BP 218, Burkina Faso
2. Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, B-2000 Antwerp, Belgium
3. Department of Microbiology, Immunology and Transplantation, Katholieke Universiteit Leuven (KU Leuven), Naamsestraat 22 Box 5401, 3000 Leuven, Belgium
4. Centre National Hospitalier Universitaire Hubert Koutoukou Maga, Cotonou 03 BP 2819, Benin
Abstract
This scoping review addresses bacterial contamination of antiseptics, low-level disinfectants, and hand hygiene products in healthcare settings in high-income countries. Over 70 years, 114 articles were found: 68 outbreaks, 13 pseudo-outbreaks and 33 cross-sectional surveys. Outbreaks affected median 29 (1–151) patients, extended for 26 (1–156) weeks and had a case fatality of 0.0% (0.0–60.0%). Most (72.8%) (pseudo-)outbreaks were caused by water-based chlorhexidine (CHG), quaternary ammonium compounds (QUAT) and the combination CHG–QUAT. Contaminating bacteria were nonfermentative Gram-negative rods (87.6% (pseudo-)outbreaks), mainly Burkholderia cepacia, Pseudomonas aeruginosa and Achromobacter spp.) and Enterobacterales (29.6%, 24/81), mostly Serratia spp.). Risk factors were at the level of the bacteria (natural resistance to CHG and QUAT), containers (design and functioning, presence of cork and cotton, biofilm formation), preparation (nonsterile water, overdilution) and practices (too long expiry dates, inappropriate container reprocessing, topping up of containers and deviation from procedures). Transmission occurred through direct contact (antiseptics), contact with semicritical items (disinfectants) and were handborne (soaps). During recent decades, reports of soap contaminated with Enterobacterales emerged and nationwide outbreaks of intrinsically contaminated CHG occurred. Outstanding issues comprise intrinsic contamination, implementation of antiseptic stewardship, the role of unit doses and sterile products, transmission studies, biofilm control and understanding healthcare providers’ perceptions.
Funder
Belgian Directorate for Development Cooperation and Humanitarian Aid
Institute of Tropical Medicine
Reference235 articles.
1. World Health Organization (WHO) (2022, August 28). Member States Information Session on Infection Prevention and Control (IPC). Available online: https://apps.who.int/iris/handle/10665/80135.
2. Modern Technologies for Improving Cleaning and Disinfection of Environmental Surfaces in Hospitals;Boyce;Antimicrob. Resist. Infect. Control,2016
3. The Role of the Healthcare Environment in the Spread of Multidrug-Resistant Organisms: Update on Current Best Practices for Containment;Chemaly;Ther. Adv. Infect. Dis.,2014
4. The Role of Patient Care Items as a Fomite in Healthcare-Associated Outbreaks and Infection Prevention;Kanamori;Clin. Infect. Dis.,2017
5. Best Practices for Disinfection of Noncritical Environmental Surfaces and Equipment in Health Care Facilities: A Bundle Approach;Rutala;Am. J. Infect. Control,2019